25.60USD+1.07%Mkt Cap: 1.01B $P/E: 196.921d ago
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The co…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap1.01B $
Enterprise Value1.22B $
Revenue (TTM)734.86M $
Gross Profit576.66M $
Net Income (TTM)7.03M $
Revenue/Share17.05 USD
Last Price25.60 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees825
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS6951271005
Valuation
P/E (Trailing)196.92
P/E (Forward)7.02
PEG11.21
EV/EBITDA10.03
EV/Revenue1.66
P/S1.37
P/B1.54
EPS (TTM)0.13
EPS (Forward)3.65
52W Range
18.8077% of range27.64
52W High27.64 USD
52W Low18.80 USD
Profitability
Gross Margin79.39%
Oper. Margin2.61%
EBITDA Margin16.50%
Profit Margin0.97%
ROE1.01%
ROA0.56%
Growth
Revenue Growth5.00%
Earnings Growth-30.00%
Cash Flow & Leverage
Operating CF151.99M $
CapEx (TTM)15.33M $
FCF Margin13.42%
FCF Yield9.79%
Net Debt209.00M $
Net Debt/EBITDA1.72
Balance Sheet
Debt/Equity0.60
Current Ratio4.73
Quick Ratio3.01
Book Value/Sh16.63 USD
Cash/Share5.138 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)29.67 USD
Upside (mean)+15.9%
Target Range23.00 USD – 38.00 USD
$23.00+15.9% to mean$38.00
# Analysts6
Ownership
Shares Out.39.35M
Float33.71M
Insiders1.77%
Institutions115.31%
Short Interest
Short Ratio13.8d
Short % Float24.21%
Short % Out.16.74%
Shares Short6.59M
Short (prev mo.)6.60M
Technical
SMA 5023.77 (+7.7%)
SMA 20023.37 (+9.6%)
Beta0.27
S&P 52W Chg20.25%
Avg Vol (30d)433.95K
Avg Vol (10d)448.06K
Technical Indicators
RSI (14)62.6
MACD0.5643
MACD Signal0.5353
MACD Hist.+0.0291
BB Upper26.96 USD
BB Middle24.62 USD
BB Lower22.27 USD
BB Width19.03%
ATR (14)0.9195 USD
Vol Ratio (20d)1.63x